CASI Pharmaceuticals, Inc. (CASIF)

0.15

0.00 (0.00%)

Revenue

Gross Profit

Operating Income

Net Income

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

Total Revenue

Cost of goods sold

Gross Profit

Operating expenses (excl. COGS)

Operating Income

Non-operating income, total

Pretax income

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

Discontinued operations

Net income

Dilution adjustment

Preferred dividends